Terms: = Sarcomas AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Prognosis
4 results:
1. Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, cdx2, p53, and MSI status.
da Silva JL; de Albuquerque LZ; Rodrigues FR; Bastos NC; Small IA; Barroso EBC; Cordero FL; Fernandes DS; Paulino E; de Melo AC
PLoS One; 2023; 18(5):e0285447. PubMed ID: 37200263
[TBL] [Abstract] [Full Text] [Related]
2. Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature.
Conforti F; Tarantino P; Trillo P; Pala L; Zagami P; Pirola S; Di Venosa B; Catania C; Queirolo P; Pennacchioli E; Della Vigna P; Curigliano G; De Pas TM
Cancer Treat Rev; 2021 Jan; 92():102133. PubMed ID: 33296826
[TBL] [Abstract] [Full Text] [Related]
3. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract] [Full Text] [Related]
4. Atypical teratoid/ rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markers.
Al-Hussaini M; Dissi N; Souki C; Amayiri N
Neuropathology; 2016 Feb; 36(1):17-26. PubMed ID: 26207291
[TBL] [Abstract] [Full Text] [Related]
